In addition, panitumumab successfully redirects CD32-CR T cells toward cancer cells overexpressing EGFR (Arriga et al, 2020; Caratelli et al, 2020; D’Aloia et al, 2016). The gene discussed is FCGR2B; the disease is cancer.